+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Retinopathy Drug"

Diabetic Retinopathy Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Diabetic Retinopathy Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Diabetic Retinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Proliferative Diabetic Retinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Proliferative Diabetic Retinopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Retinopathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Retinopathy Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 273 Pages
  • Global
From
Diabetic Retinopathy Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Diabetic Retinopathy Treatment Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 250 Pages
  • Global
From
Retinopathy of Prematurity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Retinopathy of Prematurity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 139 Pages
  • Global
From
Radiation Retinopathy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Radiation Retinopathy - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Diabetic Retinopathy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Diabetic Retinopathy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Japan Diabetic Retinopathy Therapeutic Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Diabetic Retinopathy Therapeutic Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 80 Pages
  • Japan
From
Radiation Retinopathy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Radiation Retinopathy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Diabetic Retinopathy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Diabetic Retinopathy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 171 Pages
  • Global
From
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 286 Pages
  • Global
From
Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 32 Pages
  • Global
From
Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 69 Pages
  • Global
From
Non-Proliferative Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Non-Proliferative Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 40 Pages
  • Global
From
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Regional Outlook and Forecast, 2021-2027 - Product Thumbnail Image

Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Regional Outlook and Forecast, 2021-2027

  • Report
  • March 2022
  • 157 Pages
  • Global
From
LAMEA Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027 - Product Thumbnail Image

LAMEA Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027

  • Report
  • March 2022
  • 71 Pages
  • Africa, Middle East
From
Asia Pacific Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027 - Product Thumbnail Image

Asia Pacific Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027

  • Report
  • March 2022
  • 71 Pages
  • Asia Pacific
From
North America Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027 - Product Thumbnail Image

North America Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027

  • Report
  • March 2022
  • 64 Pages
  • North America
From
Loading Indicator

The Retinopathy Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat diseases of the eye. Retinopathy drugs are used to treat diseases of the retina, such as age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. These drugs can be administered orally, topically, or by injection. Commonly used retinopathy drugs include anti-VEGF agents, corticosteroids, and photodynamic therapy. The Retinopathy Drug market is highly competitive, with many companies developing and marketing drugs to treat retinopathy. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, Roche, and Bayer. Show Less Read more